Quality of Life and Anxiety in Age Macular Degeneration Patients: A Cross-Sectional Study

Daniel Caballe-Fontanet, Cristina Alvarez-Peregrina, Neus Busquet-Duran, Eduard Pedemonte-Sarrias, Cristina Andreu-Vázquez and Miguel Ángel Sánchez-Tena
Additional contact information
Daniel Caballe-Fontanet: Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670 Madrid, Spain
Cristina Alvarez-Peregrina: Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670 Madrid, Spain
Neus Busquet-Duran: Department of Ophthalmology, Althaia Xarxa Assistencial Universitària de Manresa, 08243 Manresa, Spain
Eduard Pedemonte-Sarrias: Department of Ophthalmology, Althaia Xarxa Assistencial Universitària de Manresa, 08243 Manresa, Spain
Cristina Andreu-Vázquez: Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670 Madrid, Spain
Miguel Ángel Sánchez-Tena: ISEC LISBOA—Instituto Superior de Educação e Ciências, 1750-179 Lisboa, Portugal

IJERPH, 2022, vol. 19, issue 2, 1-9

Abstract: (1) Background: Chronic diseases affect patients’ quality of life. Age Macular Degeneration (AMD) is one of the most prevalent chronic ocular diseases. The study aims to measure the anxiety and quality of life related to vision in patients with AMD, as well as the relationship with other visual and demographic parameters. (2) Methods: Prospective cross-sectional study in AMD patients. Visual acuity (VA), contrast sensitivity (CS), line difference in the Colenbrander test, and the degree of pathology were measured. Other variables such as gender, age, and time from the diagnosis were also collected. Anxiety was measured with the Spielberger State-Trait Anxiety Inventory (STAI) and quality of life with the National Eye Institute Visual Function Questionnaire (NEI VFQ-25). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist was followed. (3) Results: Patients with higher punctuation in Trait STAI showed lower punctuation in NEI VFQ-25 questionnaire (Spearman coefficient −0.415; p = 0.001). The variables VA, CS, and age were correlated to the quality of life. The relationship between trait anxiety and subscales of NEI VFQ-25 was significant for all subscales ( p < 0.05), except for social functioning, peripheral vision, general vision, ocular pain, and driving. (4) Conclusions: AMD patients with higher levels of anxiety show a decrease in their quality of life. The quality of life of AMD patients depends on their VA and CS.

Keywords: age-related macular degeneration; STAI; NEI VFQ-25; anxiety; quality of life; AMD (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/2/820/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/2/820/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:2:p:820-:d:722988

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().